Ani Pharmaceuticals reported $95.89M in Stock for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Ani Pharmaceuticals ANIP:US USD 95.89M 3.35M
Aurora Cannabis Inc ACB:CN CAD 146.24M 6.32M
Canopy Growth Corp WEED:CN CAD 211.21M 5.7M
Depomed DEPO:US USD 14.27M 2.01M
Eli Lilly And LLY:US USD 3.83B 68.3M
Emergent Biosolutions EBS:US USD 546.3M 120.8M
Endo International Ordinary Shares ENDP:US USD 288.91M 1.16M
Heron Therapeutics HRTX:US USD 52.24M 9.08M
Hikma Pharmaceutical HIK:LN USD 765M 70M
Knight Therapeutics Inc GUD:CN CAD 84.94M 8.54M
Lannett LCI:US USD 94.12M 1.04M
Nektar Therapeutics NKTR:US USD 19.06M 2.09M
Perrigo Ordinary Shares PRGO:US USD 1.09B 5.6M
Teva Pharmaceutical TEVA:IT USD 3.86B 190M
Teva Pharmaceutical Industries TEVA:US USD 3.86B 190M